KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Common Equity (2016 - 2025)

LifeMD's Common Equity history spans 14 years, with the latest figure at $23.2 million for Q4 2025.

  • For Q4 2025, Common Equity rose 406.54% year-over-year to $23.2 million; the TTM value through Dec 2025 reached $23.2 million, up 406.54%, while the annual FY2025 figure was $23.2 million, 406.54% up from the prior year.
  • Common Equity reached $23.2 million in Q4 2025 per LFMD's latest filing, up from $1.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $23.2 million in Q4 2025 to a low of -$243.2 million in Q2 2025.
  • Average Common Equity over 5 years is -$13.7 million, with a median of -$3.5 million recorded in 2024.
  • Peak YoY movement for Common Equity: surged 1541.84% in 2022, then tumbled 12757.07% in 2025.
  • A 5-year view of Common Equity shows it stood at $21.7 million in 2021, then tumbled by 154.69% to -$11.9 million in 2022, then surged by 135.29% to $4.2 million in 2023, then plummeted by 280.33% to -$7.6 million in 2024, then skyrocketed by 406.54% to $23.2 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Common Equity are $23.2 million (Q4 2025), $1.3 million (Q3 2025), and -$243.2 million (Q2 2025).